About PRECISIS

Vision

PRECISIS improves the lives of people living with functional brain disorders – through innovative neurostimulation technologies that open new pathways in treatment.

Mission

We continuously improve EASEE® and bring the technology to epilepsy patients across Europe, with the goal of expanding into new markets step by step.

Values

Our values shape the way we collaborate, make decisions, and take responsibility — with physicians and patients at the centre. They unite team spirit, innovation, and entrepreneurial thinking.

Milestones

2015

Where It All Began

The idea for EASEE® for was born

2019

First in the World

The world’s first patient receives EASEE®

2021

Strategic Alliance

Partnership with Cochlear established

2022

Regulatory Breakthrough

  • EASEE® receives CE certification
  • EASEE® granted FDA Breakthrough Device Designation

2023

International Recognition

PRECISIS wins 1st place at the American Epilepsy Foundation Shark Tank

2024

Growing Reach

  • PRECISIS wins Health-i Award 2nd Place
  • First Patient in Portugal receives an EASEE® implant

2025

Scaling Across Europe

  • First Patients in the UK and Italy receive an EASEE® implant
  • 150 Patients treated across Europe overall
  • European Investment Bank backs PRECISIS with €20 million
  • FDA approves pivotal EASEE® IDE trial for the US
  • PRECISIS wins the WLOUNGE Tech Award and the HealthTech Investor Summit Award

Our Management

Karl Stoklosa

Managing Director, CEO

Michael Tittelbach

Managing Director, CTO

Our Advisory Board

Dr. Felix Baader

Anthony Bishop

Dr. med. Angela Liedler

André Burch

Peter Weiland

Thorben Katzer

Our Core Values

Teamwork & Trust

Trust and team spirit are the foundation of our values. What matters is not only individual strength, but what each person brings to the team. If you want to go fast, go alone. If you want to go far, go together.

Patient Orientation & Entrepreneurship

We understand the needs of everyone we serve — especially our patients — and proactively align our actions accordingly. In doing so, we combine empathy, problem-solving, and openness.

Goal-Orientation & Transparency

Dreams without goals, are just
dreams. We set high standards
of achievement whilst fostering a
work space of transparency and
respectful feedback.

Development & Innovation

Continuous development and innovation mark the difference between “good enough” and “excellent”. We invest in our people and create space for learning — open to ideas and exchange.

Responsibility & Commitment

Each of us is responsible for staying focused and engaged. Together, we stand up for our customers, our people, and above all our patients.

Role Model & Appreciation

We are role models and represent the company. Our actions are guided by integrity, respect, and openness – equal treatment is a given for us.

More about us on LinkedIn

Follow us on LinkedIn for the latest from PRECISIS — clinical updates, milestones, team news, and insights from the world of neurotech and epilepsy care.

Go to LinkedIn

Strong Innovations with Strong Funding

Cochlear

In 2021, Precisis and Cochlear Ltd. in Australia entered into a partnership. Through this newly established relationship with Cochlear, Precisis benefits from financial advantages and Cochlear’s scientific expertise. Cochlear is the world’s leading provider of implantable hearing solutions. The company employs more than 4,000 people worldwide and invests more than 180 million AUD in research and development each year. It’s products include hearing systems for cochlear implants, bone-conduction implants, and acoustic implants, which are designed to treat moderate to severe hearing loss. Since 1981, the company has provided more than 650,000 implantable devices that help people of all ages in approximately 180 countries to hear.

Open Website

News

Discover more from PRECISIS

PRECISIS GmbH, based in Heidelberg, develops bioelectronic therapies that target the very source of neurological diseases – the brain itself. Learn more about our technology, our team, and the vision behind EASEE® for epilepsy.

About PRECISIS

News

Product

Career

Subscribe to the newsletter